NCT04017299

Brief Summary

This is a feasibility study of electronic devices in order to reduce neuro-psychological disorders and suffering in intensive care unit (ICU) patients. A first step study is necessary to define which device is effective and safe to reduce symptom intensities, among music therapy, virtual reality with real pictures, virtual reality with artificial pictures, and common devices (radio or television). If some devices are effective to reduce patients' symptoms, a second step will be to implement and assess the impact of these tools in a multicenter trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 5, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 12, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

July 17, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

July 5, 2019

Last Update Submit

September 29, 2025

Conditions

Keywords

ICUPainAnxietyThirstDyspneaSleepDiscomfortDistressVirtual RealityMusic Therapy

Outcome Measures

Primary Outcomes (1)

  • Variation of intensity of the 5 discomfort symptoms (pain, anxiety, thirst, dyspnea, insomnia) assessed by a self-report 0-10 visually enlarged numeric rating scale

    Just after the use of each device (up to 20 minutes)

Secondary Outcomes (6)

  • Variation of physiologic parametres (Heart Rate, Blood pressure, Respiratory rate and Analgesia nociception Index), evaluation of feasibility and feelings concerning the distraction devices.

    ICU discharge (up to Day 28)

  • Variation of Respiratory rate during the use of each device

    up to 20 minutes (after the device use )

  • Variation of physiologic Blood pressure during the use of each device

    up to 20 minutes (after the device use )

  • Variation of Heart Rate during the use of each device

    up to 20 minutes (after the device use )

  • evaluation of feasibility assessed by the Numeric Rating Scale from 0 to 10

    just after the use of each device (up to 20 minutes)

  • +1 more secondary outcomes

Study Arms (4)

Virtual reality with computer graphics

ACTIVE COMPARATOR

Use of Virtual reality with computer graphics

Other: CHOISIR

Virtual reality with real movies

ACTIVE COMPARATOR

Use of Virtual reality with real movies

Other: CHOISIR

Music therapy (dedicated device and music scores)

ACTIVE COMPARATOR

Use of music therapy (dedicated device and music scores)

Other: CHOISIR

Usual device (TV radio)

OTHER

usual distraction : watching TV

Other: CHOISIR

Interventions

CHOISIROTHER

Every patient will evaluate each device after 15 minutes of distraction once or twice a day according to the patient's wishes.

Music therapy (dedicated device and music scores)Usual device (TV radio)Virtual reality with computer graphicsVirtual reality with real movies

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient admitted in intensive care unit,
  • adult,
  • French speaking,
  • awake (RASS ≥ -1),
  • not delirious (CAM-ICU negative),

You may not qualify if:

  • patient refusal
  • psychosis or preexisting cognitive dysfunction
  • cerebral injury,
  • hygiene/microbiological harm,
  • pregnancy,
  • decision of withdrawal of care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Montpellier Hospital

Montpellier, 34295, France

Location

MeSH Terms

Conditions

PainAnxiety DisordersDyspnea

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, Respiratory

Study Officials

  • Gérald CHANQUES, PhD

    University of Montpellier Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2019

First Posted

July 12, 2019

Study Start

July 17, 2019

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

identified data used in the published manuscript will be shared in accordance with the applicable informed consent under which the data was collected

Time Frame
12 months after the main publication
Access Criteria
Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and IRB review. Dataset will be shared after careful examination by the study board of investigators.

Locations